68Ga-MY6349

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug Name68Ga-MY6349
Drug Alias Name68Ga-MY634968Ga-THP-Trop2 VHH
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesThe First Affiliated Hospital Of Xiamen UniversityThe First Affiliated Hospital of Air Force Medical UniversityBeijing Tiantan Hospital, Capital Medical University
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Tiantan Hospital, Capital Medical UniversityThe First Affiliated Hospital Of Xiamen University
Inactive CompaniesThe First Affiliated Hospital of Air Force Medical University
Active IndicationsSolid tumoursProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[5] 
Inactive IndicationsThyroid NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A